Fibromyalgia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with fibromyalgia:
- A doctor has confirmed a fibromyalgia diagnosis using the 2011 American College of Rheumatology classification criteria
- Pain has been present on more than half of days during the past month
- Average pain over the past 7 days has been rated at least 3 out of 10 on a pain scale
- Willingness to avoid starting new medications or treatments for fibromyalgia during the study
- Being right-handed
- Able to travel to the study site to receive brain stimulation treatments five times per week
- Willingness and ability to complete all study procedures
- Able to give written informed consent
For healthy volunteers (comparison group):
- Being right-handed
- Pain rated less than 0.5 out of 10 on a pain scale over the past 7 days
- Willingness and ability to complete all study procedures
- Able to give written informed consent
Who may not be able to join:
For people with fibromyalgia:
- Having another autoimmune or inflammatory condition (such as rheumatoid arthritis or lupus) that also causes pain
- A history of head injury involving significant loss of consciousness
- Having nerve damage from a known cause that interferes with everyday activities
- Daily use of opioid painkillers or marijuana, or a history of substance abuse
- Currently taking stimulant medications such as those used for ADHD (for example, Adderall, methylphenidate) or wakefulness medications such as modafinil
- Currently taking part in another treatment trial
- Taking over-the-counter pain medications (such as anti-inflammatories) on the day of brain or imaging scans
- Having taken opioid painkillers within 48 hours before a brain or imaging scan
- Currently pregnant or breastfeeding (a pregnancy test will be done before scan sessions)
- Having a serious psychiatric illness such as active schizophrenia, major depression with thoughts of suicide, or substance abuse within the past two years
- Having metal implants, surgical clips, staples, or certain dental metalwork that would make brain stimulation or scanning unsafe
- Having detailed prior knowledge of the brain stimulation technique used in this trial, or having previously received this type of treatment, in a way that could affect study blinding
- Having any other factor that the study team determines would prevent safe or reliable participation in the study
- A history of vascular surgery on the lower limbs, or current circulation problems in the lower limbs
- Currently involved in workers' compensation claims, legal action, disability claims, out-of-court settlements, or receiving financial compensation related to fibromyalgia
- Unwillingness or inability to give written informed consent
For healthy volunteers:
- Meeting the criteria for a fibromyalgia diagnosis
- Having any ongoing medical condition, including psychiatric disorders such as psychosis or schizophrenia (based on self-report)
- A history of head injury involving significant loss of consciousness
- Having nerve damage from a known cause that interferes with everyday activities
- Daily use of opioid painkillers or marijuana, or a history of substance abuse
- Currently taking stimulant medications such as those used for ADHD, or wakefulness medications such as modafinil
- Currently taking part in another treatment trial
- Currently pregnant or breastfeeding (a pregnancy test will be done before scan sessions)
- Having metal implants or other factors that would make brain or imaging scans unsafe
- Taking over-the-counter pain medications on the day of a scan
- Having taken opioid painkillers within 48 hours before a scan
- A history of substance use disorder in the past 24 months (based on self-report)
- A history of vascular surgery on the lower limbs, or current circulation problems in the lower limbs
- Any other factor that the study team determines would prevent satisfactory completion of the study
- Unwillingness or inability to give written informed consent
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alexandre Dasilva, DDs,DMedsc, University of Michigan
Phone: 734-998-6839
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Aim 1 - Brain EEG metric of ES obtained at Visit 1: Correlation between EEG alpha band degree and frequency.; Aim 3 - Change in brain EEG metrics of ES: Change from visit 8 to visit 14 in correlation of EEG alpha band degree and frequency.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.